Transcatheter Mitral Valve Replacement in Failed Bioprosthetic Valve, Ring, and Mitral Annular Calcification Associated Mitral Valve Disease Using Balloon Expandable Transcatheter Heart Valve.

• Type of Material: Article
• Authors: Hiroki A Ueyama, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, Georgia, US.; Patrick Gleason, Emory University; Vasilis Babaliaros, Emory University; Adam Greenbaum, Emory University
• Language: English
• Date: 2023
• Publisher: Houston Methodist DeBakey Heart & Vascular Center
• Publication Version: Final Published Version
• Copyright Statement: © 2023 The Author(s)
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.14797/mdcvj.1221
• Title of Journal or Parent Work: Methodist Debakey Cardiovasc J
• Volume: 19
• Issue: 3
• Start Page: 37
• End Page: 49
• Keywords: Calcinosis; Treatment Outcome; Humans; Mitral Valve Insufficiency; Cardiac Catheterization; Heart Valve Prosthesis Implantation; transcatheter mitral valve replacement; mitral valve disease; mitral annular calcification; Heart Valve Diseases; Heart Valve Prosthesis; Mitral Valve
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

Transcatheter mitral valve replacement (TMVR) using the SAPIEN platform has been performed in failed bioprosthetic valves (valve-in-valve), surgical annuloplasty rings (valve-in-ring), and native valves with mitral annular calcification (MAC) (valve-in-MAC). Experience over the past decade has identified important challenges and solutions to improve clinical outcomes. In this review, we discuss the indication, trend in utilization, unique challenges, procedural planning, and clinical outcomes of valve-in-valve, valve-in-ring, and valve-in-MAC TMVR.